The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Alizin 30 mg/ml Solution for Injection

Virbac S.A.VPA10988/066/001

Main Information

Trade NameAlizin 30 mg/ml Solution for Injection
Active SubstancesAglepristone
Dosage FormSolution for injection
Licence HolderVirbac S.A.
Licence NumberVPA10988/066/001

Group Information

ATC CodeQG03XB90 aglepristone
Therapeutic ClassHormone


License statusAuthorised
Licence Issued07/05/2004
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back